ImmunoCellular Therapeutics

Public:
Nasdaq: IMUC

Headquarters:
Calabasas, CA

Deal Team:
Lou Lange

Developer of active immunotherapies to target regular tumor cells as well as cancer stem cells believed to cause cancer growth and reoccurrence

AMV

AMV is a venture capital firm investing in
early-stage digital health, technology and
life sciences companies.

 

2100 Geng Road, Suite 200
Palo Alto, CA
650.621.8808

© 2017 Asset Management Ventures
All Rights Reserved